Radiopharmaceuticals Market is worth $5.55 Billion by 2017 - PowerPoint PPT Presentation

About This Presentation
Title:

Radiopharmaceuticals Market is worth $5.55 Billion by 2017

Description:

Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13), [SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography – Forecasting - 2017 – PowerPoint PPT presentation

Number of Views:132

less

Transcript and Presenter's Notes

Title: Radiopharmaceuticals Market is worth $5.55 Billion by 2017


1
MarketsandMarkets Presents
Nuclear Medicine Market
http//www.marketsandmarkets.com/Market-Reports/ra
diopharmaceuticals-market-417.html
2
The Nuclear Medicine Market Radiopharmaceutical
s SPECT/PET Radioisotopes (Technetium, F-18),
Beta/Alpha Radiation Therapy (I131, Y-90),
Applications (Cancer/Oncology, Cardiac)
Stable Isotopes (Deuterium, C-13) Global Trends
Forecast To 2017 analyzes and studies the major
market drivers, restraints, and opportunities in
North America, Latin America, Europe, Asia, and
Rest of the World. Browse gtgt
144 market data tables 44
figures 346 pages Report In-depth TOC
on Nuclear Medicine Market  Radiopharmaceuticals
http//www.marketsandmarkets.com/Market-Reports
/radiopharmaceuticals-market-417.html
3
This report studies the global nuclear medicine
market over the forecast period 2012-2017.The
global radiopharmaceutical market was valued at
3.8 billion in 2012 and is poised to reach 5.5
billion by 2017 at a CAGR of 7.8. The
radioisotopes market is categorized into
diagnostic and therapeutic applications. The
diagnostic market consists of PET and SPECT
technologies, while the therapy market comprises
of beta emitters and brachytherapy seeds. The
SPECT market accounted for a major share of the
diagnostic segment in 2012. Significant
radioisotopes in the SPECT diagnostic market are
Tc-99m, Tl- 201, Ga-67, and I-123, while PET
market is dominated by F-18, and Rb-82. The
therapy market is led by I-131, Sm-153, Re-186,
Y-90, and Lu-177. Alpha emitters are being
developed and considered for cancer treatment,
however not available commercially.
http//www.marketsandmarkets.com/Market-Reports/ra
diopharmaceuticals-market-417.html
4
Increasing use of SPECT and PET scans, technical
advancements in equipment and other factors such
as rising awareness of radiopharmaceuticals among
physicians, alpha radioimmunotherapy based
targeted cancer treatment, and ready availability
of radiopharmaceutical from cyclotrons have
driven the market. High cost of devices using
radioisotopes, short half-life, lack of good
manufacturing practices, and stringent regulatory
approvals are major hurdles to growth of the
market. North America is the dominant market for
diagnostic radioisotopes with close to half of
the market share. The U.S. is the largest
consumer market for radiopharmaceuticals, while
Canada is one of the largest producers of Tc-99m.
http//www.marketsandmarkets.com/Market-Reports/ra
diopharmaceuticals-market-417.html
5
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/ra
diopharmaceuticals-market-417.html
6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/ra
diopharmaceuticals-market-417.html
Write a Comment
User Comments (0)
About PowerShow.com